BIOMARKER DISCOVERY FOR PATHOLOGICAL PLACENTAL MALARIA

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 摩尔博士研究项目的目标是确定病理性胎盘疟疾的生物标志物。我们合作的实验方法将是阐明使用我们的qRT-PCR平台用各种刺激处理后合胞体滋养层中聚糖相关基因表达的变化。先前关于胎盘疟疾的文献报道暗示了糖胺聚糖（GAG）的作用（即，硫酸软骨素A）在疟疾感染中的作用。 我们最初的实验将包括评估GAG相关基因的转录丰度。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The goal of Dr. Moore's research program is to identify biomarkers for pathological placental malaria. The experimental approach for our collaboration will be to elucidate changes in glycan-related gene expression in syncytiotrophoblast following treatment with various stimuli using our qRT-PCR platform. Previous reports in the literature on placental malaria have implicated a role for glycosaminoglycans (GAGs)(ie. Chondriotin Sulfate A) in malarial infection. Our initial experiments will include evaluation of transcript abundance of GAG-related genes.